Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × penclomedine × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Obesity 1 Fatty Liver 1

Interventions

naloxegol 7 Radiotherapy 6 Metformin 5 Exenatide 4 Cisplatin 4 Surveys and Questionnaires 3 Water 2 Vitamin D 2 Therapeutics 2 Testosterone 2 Sugars 2 Radiation 2 Methods 2 Injections 2 Dexamethasone 2 Calcium Dobesilate 2 Anastrozole 2 prucalopride 1 peppermint oil 1 penclomedine 1 pegfilgrastim 1 oxycodone-acetaminophen 1 methylnaltrexone 1 linaclotide 1 licogliflozin 1 kang-lai-te 1 isatuximab 1 exemestane 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02157974 2024-06-04

APPLE

University of Colorado, Denver

Phase 2/3 Completed

92 enrolled 17 charts

Fatty Liver, Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡